GABBR2 p.Pro20Ser
c.58C>T · rs1430262254 · VCV949372
Computational evidence
| Protein change | ||
| AlphaMissense | 0.0923 | likely benign |
|---|---|---|
| REVEL | 0.18 | moderately benign-leaning |
| SaProt | LLR -8.91 | tolerated |
| ⇒ AlphaMissense, REVEL and SaProt all call this tolerated. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 0.6 | GERP 1, phastCons 0.99 |
| Regional constraint | o/e 0.95 | unconstrained · MANE · 164 bp · p 0.69 · regional, not allelic |
| Overall | ||
| CADD | 18.35 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| European (non-Finnish)grpmax | 0.00638% | 15,667 |
| Remaining individualsnot grpmax-eligible | 0.00282% | 35,484 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- GABBR2
- Protein
- p.Pro20Ser
- Coding
- c.58C>T
- MANE Select
- NM_005458
- dbSNP
- rs1430262254
- Type
- single nucleotide variant
- Location
- chr9:98708680 (GRCh38)
- Gene constraint
- LOEUF 0.394 · pLI 1.00 (gnomAD)
- Structure
- AlphaFold pLDDT 78.00 · 26 PDB
Similar variants
- GABBR2 p.Pro20= Likely benign ★ same residue
- GABBR2 p.Ala570Thr Uncertain significance ★★ ⚠ same condition
- GABBR2 p.Ala912Thr Uncertain significance ★★ ⚠ same condition
- GABBR2 p.Arg197Cys Uncertain significance ★★ ⚠ same condition
- GABBR2 p.Arg799Gln Uncertain significance ★★ same condition
- GABBR2 p.Gln194His Uncertain significance ★★ ⚠ same condition
- GABBR2 p.Glu320Gln Uncertain significance ★★ same condition
- GABBR2 p.Gly671Ser Uncertain significance ★★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/gabbr2-p-pro20ser (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown